BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Encore Therapeutics Inc. 



Carlsbad  California    U.S.A.
Phone: 619-787-4083 Fax:


SEARCH JOBS


Industry
Pharmaceutical






 Company News
Encore Therapeutics Inc. Announces Successful Proof of Concept Study on Meloxicam Depot Injection 10/18/2011 11:15:26 AM    More...
Encore Therapeutics Inc. Announces Extended Release Depot Formulation of Ropivacaine Available for License 9/26/2011 10:40:38 AM    More...
Progesterone and TBI: Encore Therapeutics Inc. Completes Novel Commercially Enabling Progesterone Formulation for TBI 5/10/2011 10:21:47 AM    More...
Encore Therapeutics Inc. Announces Depot Meloxicam Formulation Enabling Local High Drug Dose Delivery 4/4/2011 8:09:37 AM    More...
Encore Therapeutics Inc. Demonstrates Proof of Concept for a Long-acting Buprenorphine Depot for Pain and Drug Abuse Therapy (ETI-311) 12/8/2008 12:38:58 PM    More...
PainReform Licenses a Novel Sustained Release Formulation of Ropivacaine from Encore Therapeutics Inc. 7/2/2008 9:52:11 AM    More...
Novel Progesterone Formulation for Stroke and Traumatic Brain Injury Developed by Encore Therapeutics Inc. 6/24/2008 9:42:46 AM    More...
Encore Therapeutics Inc. Reports Additional Proof of Concept Results on its Extended Release Ropivacaine Injectable Gel for Postoperative Pain Management 8/2/2007 1:12:26 PM    More...
Encore Therapeutics Inc. Reports Efficacy Data On A Long-Acting Local Anesthetic Drug 1/30/2007 12:26:05 PM    More...

//-->